DNP International Named Ingredient Distributor for Shugr; International Distribution Positions Shugr for Blockbuster Sales Potential.

LOS ANGELES -- Health Sciences Group, Inc. (OTCBB:HESG), provider of innovative nutritional products and functional food ingredients derived from natural sources, announced today that it has signed a non-exclusive distribution agreement with DNP International Co., Inc. to distribute its Swiss Diet(R) Shugr(TM) sweetener as a raw material ingredient to manufacturers nationwide and globally. DNP International is a leading importer and distributor of raw materials to manufacturers in the food, beverage and nutritional supplement industries, among others.

"We are extremely pleased to have DNP as our primary raw material distributor of Shugr(TM)," said Fred E. Tannous, Co-chairman and CEO of Health Sciences Group, Inc. "Our partnership with DNP allows us to broaden our commercial marketing and sales reach, it provides us access to the raw material ingredients marketplace and moves us one step further in our international growth strategy. Because of its great taste, natural profile, low glycemic index and excellent cooking and baking qualities, Shugr(TM) is expected to become the sweetener of choice for many manufacturers who seek a natural, zero-calorie replacement for cane sugar or other sweeteners in their diet and diabetic-friendly products. We believe our partnership with DNP will allow us to, not only increase the exposure for Shugr(TM) in this category, but also generate significant revenues from worldwide sales of Shugr(TM) as a raw material ingredient."

"We see a distinct need in the marketplace for an alternative non-nutritive sweetener, and we feel that Shugr(TM) fills this need perfectly," said Hovsep Margaryan, Vice President of DNP International. "We're particularly impressed with the taste, which is virtually indistinguishable from table sugar. We feel this offers a significant advantage to manufacturers, who will no longer need to mask the aftertaste of other non-nutritive sweeteners. And, since Shugr is 99.5% natural, we believe it will appeal to consumers concerned about synthetic sweeteners."

Shugr(TM) is made from sugars that occur naturally in such good-tasting, healthy foods such as fruits, vegetables, corn and dairy products. Called erythritol, maltodextrin and tagatose, these natural sugars provide a clean and delicious sweet taste. Erythritol is commonly found in melon, grapes, mushrooms and soy. Maltodextrin is derived from corn sugar, which is non-GMO and gluten-free. Tagatose comes from dairy products, but does not affect people who are lactose intolerant. Tagatose also provides an added health benefit -- prebiotic fiber that promotes intestinal health, much the way yogurt does. All of these ingredients carry a GRAS (Generally Recognized As Safe) designation for food safety from the US Food & Drug Administration.

Shugr(TM) does not contain any aspartame, neotame, saccharin, fructose, high fructose corn syrup, acesulfame-K, cane sugar, honey or stevia.

"As a complement to our overall retail strategy, we believe the distribution of Shugr(TM) as a raw material ingredient greatly enhances its market appeal and acceptance," said Bill Glaser, Co-chairman and President of Health Sciences Group. "We believe our distribution agreement with DNP will aid us in achieving this objective and pave the path to making Shugr(TM) a blockbuster product."

About Health Sciences Group, Inc.

Health Sciences Group identifies, develops and commercializes innovative nutritional products derived from natural sources to provide consumers and medical professionals with preventative healthcare alternatives. The company markets its own line of proprietary products based on novel technologies with clinically-supported, GRAS-certified ingredients under its Swiss Research(TM) and Swiss Diet(TM) brand names. For more information, visit www.HSciences.com.

About Swiss Research, Inc.

Swiss Research, Inc. markets and sells branded nutraceutical products addressing major wellness categories, including weight management, arthritis support, cholesterol reduction and diabetes management. SwissDiet(R), its line of weight-loss products, includes Shugr(R), the world's first natural, diabetes-friendly, zero-calorie sweetener that looks, tastes and cooks like sugar; proprietary diet capsules, SlimSupport(TM) capsules for craving control, CalorieMinus(TM) peppermint wafers for fat absorption, MealSource(TM) meal replacement powdered drink mix, and SlimSource(TM) nutritional energy drink mix. Other unique and innovative products, marketed under the Swiss Research(R) brand name, include Sequestrol(TM), a natural proprietary nutritional supplement and functional ingredient which is clinically proven to assist in the reduction of low-density lipoprotein (LDL) cholesterol and triglyceride levels; and CellSource(TM) for joint relief and flexibility. Swiss Research distributes its products through national retail channels as well as online. For more information, visit www.SwissDiet.com and www.Shugr.com.

About DNP International, Inc.

DNP International, Inc. imports and distributes raw material ingredients to manufacturers in the food, beverage, dietary supplement, cosmetic and pharmaceutical industries. Founded in 1994, DNP is one of the largest suppliers of raw materials in the United States sourcing over two thousand different ingredients. Headquartered in Irvine, California, DNP has locations in Los Angeles, Chicago and New Jersey. For more information, visit www.dnpint.com.

This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934 that are based upon current expectations or beliefs, as well as a number of assumptions about future events. Although the Company believes that the expectations reflected in the forward-looking statements and the assumptions upon which they are based are reasonable, it can give no assurance that such expectations and assumptions will prove to have been correct. The reader is cautioned not to put undue reliance on these forward-looking statements, as these statements are subject to numerous factors and uncertainties, including without limitation, the independent authority of the special committee to act on the matters discussed, the successful negotiation of the potential acquisition and disposal of transactions described above, successful implementation of the company's business strategy and competition, any of which may cause actual results to differ materially from those described in the statements. In addition, other factors that could cause actual results to differ materially are discussed in the Company's most recent Form 10-QSB and Form 10-KSB filings with the Securities and Exchange Commission.